DocMeetings

11β-Hydroxysteroid dehydrogenase type 1 inhibition protects against the development of adverse metabolic and bone effects of prednisolone: A randomized, double-blind, placebo-controlled trial.

European Society of Endocrinology

9/7/20, 5:00 PM

Europe/Paris GMT+2

Description

​

​

Inglês

Speakers

Nantia Othonos

Link to the Event

https://ese-hormonesprogram.m-anage.com/eece2020/en-GB/ProgramSearch/Program/?searchstring=&programid=81947&pProgramGrade=All&pHideLogin=False&pHidePersonal=False&pShowPrivate=False

Banner to the Event

Register your event here

Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.